pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLC10.18093/0869-0189-2006-6-118-122pulmo-1518Research ArticleСтатьиЗначимость измерения окиси азота выдыхаемого воздуха
при болезнях органов дыханияБиличенкоТ.Н.noemail@neicon.ruБалдуеваМ.Ф.noemail@neicon.ru20062812200606118122Copyright © Биличенко
Т., Балдуева
М., 20062006Биличенко
Т., Балдуева
М.Биличенко
Т., Балдуева
М.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/1518ReferencesPalmer R.M.J, Ferridge A.G., Moncada S. Release accounts for the biological activity of endothelium-derived-relaxing factor. Nature 1987; 327: 524-526.Palmer R.M.J, Ferridge A.G., Moncada S. Release accounts for the biological activity of endothelium-derived-relaxing factor. Nature 1987; 327: 524-526.Robbins R.A., Barnes P.J., Springall D.R., et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 1994; 203: 209-218.Robbins R.A., Barnes P.J., Springall D.R., et al. Expression of inducible nitric oxide in human lung epithelial cells. Biochem. Biophys. Res. Commun. 1994; 203: 209-218.Grasemann H., Yandava C.N. Storm van's Gravesande K. et al. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem. Biophys. Res. Commun. 2000; 272: 391-394.Grasemann H., Yandava C.N. Storm van's Gravesande K. et al. A neuronal NO synthase (NOS1) gene polymorphism is associated with asthma. Biochem. Biophys. Res. Commun. 2000; 272: 391-394.Gao P.S., Kawada H., Kasamatsu T., et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem. Biophys. Res. Commun. 2000; 267: 361-363.Gao P.S., Kawada H., Kasamatsu T., et al. Variants of NOS1, NOS2, and NOS3 genes in asthmatics. Biochem. Biophys. Res. Commun. 2000; 267: 361-363.Meyer M., Schuster K.D., Schulz H., Mohr M., Piiper J. Pulmonary diffusing capacities for nitric oxide and carbon monoxide determined by rebreathing in dogs. J. Appl. Physiol. 1990; 68: 2344-2357.Meyer M., Schuster K.D., Schulz H., Mohr M., Piiper J. Pulmonary diffusing capacities for nitric oxide and carbon monoxide determined by rebreathing in dogs. J. Appl. Physiol. 1990; 68: 2344-2357.Abman S.H. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr. Opin. Pediatr. 1994; 6: 239-247.Abman S.H. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension. Curr. Opin. Pediatr. 1994; 6: 239-247.Barnes P.J. Nitric oxide and airway disease. Ann. Med. 1995; 27: 389-393.Barnes P.J. Nitric oxide and airway disease. Ann. Med. 1995; 27: 389-393.Barnes P.J. Neural mechanisms in asthma. Br. Med. Bull. 1992; 48: 149-168.Barnes P.J. Neural mechanisms in asthma. Br. Med. Bull. 1992; 48: 149-168.Gutierrez H.H., Chumley P., Rivera A., Freeman B.A. Nitric oxide regulation of superoxide-dependent lung cell injuri: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Fre Radic. Biol. Med. 1996; 21: 43-52.Gutierrez H.H., Chumley P., Rivera A., Freeman B.A. Nitric oxide regulation of superoxide-dependent lung cell injuri: oxidant-protective actions of endogenously produced and exogenously administered nitric oxide. Fre Radic. Biol. Med. 1996; 21: 43-52.Gaston B., Reilly J., Drazen J.M., et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA. 1993; 90: 10957-10961.Gaston B., Reilly J., Drazen J.M., et al. Endogenous nitrogen oxides and bronchodilator S-nitrosothiols in human airways. Proc. Natl. Acad. Sci. USA. 1993; 90: 10957-10961.Gustafsson L.E., Leone A.M., Persson M.G., Wiklund N.P., Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 1991; 181: 852-857.Gustafsson L.E., Leone A.M., Persson M.G., Wiklund N.P., Moncada S. Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem. Biophys. Res. Commun. 1991; 181: 852-857.Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatic. Eur. Resp. Jour. 1993; 6: 1368-1370.Alving K., Weitzberg E., and Lundberg J.M. Increased amount of nitric oxide in exhaled air of asthmatic. Eur. Resp. Jour. 1993; 6: 1368-1370.Schilling J., Holzer P., Guggenbach M. et al. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur. Resp. Jour. 1994; 7: 467-471.Schilling J., Holzer P., Guggenbach M. et al. Reduced endogenous nitric oxide in the exhaled air of smokers and hypertensives. Eur. Resp. Jour. 1994; 7: 467-471.Schedin U., Frostell C., Persson M.G. et al. Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans. Acta Anaesthesiol. Scand. 1995; 39: 327-332.Schedin U., Frostell C., Persson M.G. et al. Contribution from upper and lower airways to exhaled endogenous nitric oxide in humans. Acta Anaesthesiol. Scand. 1995; 39: 327-332.Giraud G.D., Nedjanik B., Kimberly B., Holden W.E. Physical characteristics and gas composition of nasal air affect nasal nitric oxide release. Respir. Physiol. 1998; 114; 285-296.Giraud G.D., Nedjanik B., Kimberly B., Holden W.E. Physical characteristics and gas composition of nasal air affect nasal nitric oxide release. Respir. Physiol. 1998; 114; 285-296.Rinder J., Lundberg J.O.N., Anggard A. et al. Effects of topical nasal decongestants, L-arginine and nitric oxide synthase inhibition, on nasal cavity nitric oxide levels and nasal cavity volume in man. Am. J. Rhinol. 1996; 10: 399-408.Rinder J., Lundberg J.O.N., Anggard A. et al. Effects of topical nasal decongestants, L-arginine and nitric oxide synthase inhibition, on nasal cavity nitric oxide levels and nasal cavity volume in man. Am. J. Rhinol. 1996; 10: 399-408.Silkoff Ph.E., and Zamel N. Exhaled Nitric Oxide. RT international. 1997; 75-79.Silkoff Ph.E., and Zamel N. Exhaled Nitric Oxide. RT international. 1997; 75-79.Kharitonov S.A., Alving K., Barnes P.J. Task Force Report. Exhaled and nitric oxide measurements: recommendations. Eur. Respir. Jour. 1997; 10: 1683-1693.Kharitonov S.A., Alving K., Barnes P.J. Task Force Report. Exhaled and nitric oxide measurements: recommendations. Eur. Respir. Jour. 1997; 10: 1683-1693.American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in Adults and Children 1999. Am. J. Respir. Crit. Care Med. 1999; 160: 2104-2117.American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in Adults and Children 1999. Am. J. Respir. Crit. Care Med. 1999; 160: 2104-2117.Baraldi E., de Jongste J.C. Measurement of exhaled nitric oxide in children, 2001. Eur. Resp. Jour. 2002; 20: 223-237.Baraldi E., de Jongste J.C. Measurement of exhaled nitric oxide in children, 2001. Eur. Resp. Jour. 2002; 20: 223-237.Massaro A.F., Mehta S., Lilly C.M. et al. Elevated nitric oxide concentrations in isolated lower respiratory tract. Am. J. Respir. Crit. Care Med. 1996; 153: 1510-1514.Massaro A.F., Mehta S., Lilly C.M. et al. Elevated nitric oxide concentrations in isolated lower respiratory tract. Am. J. Respir. Crit. Care Med. 1996; 153: 1510-1514.Silkoff P. E., Caramori M., McClean P. et al. Exhaled pulmonary nitric oxide measured at a standardized low flow rate is increased in bronchial asthma and falls rapidly after inhaled steroid. Eur. Resp. J. 1996; 9: 14s. Abstract.Silkoff P. E., Caramori M., McClean P. et al. Exhaled pulmonary nitric oxide measured at a standardized low flow rate is increased in bronchial asthma and falls rapidly after inhaled steroid. Eur. Resp. J. 1996; 9: 14s. Abstract.Bisgaard H., Loland L., Oj J.A. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am. J. Respir. Crit. Care Med. 1999; 160: 1227-1231.Bisgaard H., Loland L., Oj J.A. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am. J. Respir. Crit. Care Med. 1999; 160: 1227-1231.Fuglsang G., Vikre-Jorgensen J., Agertoft L., Pedersen S. Effect of salmeterol treatment on nitric oxide level in exhaled air and doseresponse to terbutaline in children with mild asthma. Pediatr. Pulmonol. 1998; 25: 314-321.Fuglsang G., Vikre-Jorgensen J., Agertoft L., Pedersen S. Effect of salmeterol treatment on nitric oxide level in exhaled air and doseresponse to terbutaline in children with mild asthma. Pediatr. Pulmonol. 1998; 25: 314-321.Kharitonov S.A., Wells A.U., O'Connor B.J. et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 1995; 151: 1889-1893.Kharitonov S.A., Wells A.U., O'Connor B.J. et al. Elevated levels of exhaled nitric oxide in bronchiectasis. Am. J. Respir. Crit. Care Med. 1995; 151: 1889-1893.Kelley T.J., M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 1998; 102: 1200-1207.Kelley T.J., M.L. Inducible nitric oxide synthase expression is reduced in cystic fibrosis murine and human airway epithelial cells. J. Clin. Invest. 1998; 102: 1200-1207.Karadag B., James A.J., Gultekin E., Wilson N.M., Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary diskinesia. Eur. Resp. J. 1999; 13: 1402-1405.Karadag B., James A.J., Gultekin E., Wilson N.M., Bush A. Nasal and lower airway level of nitric oxide in children with primary ciliary diskinesia. Eur. Resp. J. 1999; 13: 1402-1405.Lanz M.J., Lin A.H., Buchmeier A.D., Nelson H.S. Nasal nitric oxide (nNO) decreases in children with grass pollen allergy with oral cetirizine syrup. J Allergy clin immunol. 1998; abstracts,: s244, 1013.Lanz M.J., Lin A.H., Buchmeier A.D., Nelson H.S. Nasal nitric oxide (nNO) decreases in children with grass pollen allergy with oral cetirizine syrup. J Allergy clin immunol. 1998; abstracts,: s244, 1013.Hanazawa T., Antuni J.D., Kharitonov S.A., Banes P.J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2000; 105: 58-64.Hanazawa T., Antuni J.D., Kharitonov S.A., Banes P.J. Intranasal administration of eotaxin increases nasal eosinophils and nitric oxide in patients with allergic rhinitis. J. Allergy Clin. Immunol. 2000; 105: 58-64.Kang B.H., Chen S.S., Jou L.S., Weng P.K., Wang H.W. Immunolocalization of inducible nitric oxide synthase and 3-nitrotyrosine in the nasal mucosa of patients with rhinitis. Eur Arch Otorhinolaryngol. 2000; 257(5):242-6.Kang B.H., Chen S.S., Jou L.S., Weng P.K., Wang H.W. Immunolocalization of inducible nitric oxide synthase and 3-nitrotyrosine in the nasal mucosa of patients with rhinitis. Eur Arch Otorhinolaryngol. 2000; 257(5):242-6.Baraldi E., Azzolin N.M., Carra S. et al. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir. Med. 1998; 92: 558-561.Baraldi E., Azzolin N.M., Carra S. et al. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir. Med. 1998; 92: 558-561.Kharitonov S.A., Karalasingam R., B.O'Connor et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoides. J. Allergy Clin Immun. 1997; 99: 58-64).Kharitonov S.A., Karalasingam R., B.O'Connor et al. Nasal nitric oxide is increased in patients with asthma and allergic rhinitis and may be modulated by nasal glucocorticoides. J. Allergy Clin Immun. 1997; 99: 58-64).Vosswinkel R, Neidt I, Bothe H. The production and utilization of nitric oxide by a new denitrifying strain of Pseudomonas aerugenosa. Arch Microbiol. 1991; 156: 62-69.Vosswinkel R, Neidt I, Bothe H. The production and utilization of nitric oxide by a new denitrifying strain of Pseudomonas aerugenosa. Arch Microbiol. 1991; 156: 62-69.Henriksen A.H., Sue-Chu M., Lingaas Holmen T. et al. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur. Resp. J. 1999; 13: 301- 306.Henriksen A.H., Sue-Chu M., Lingaas Holmen T. et al. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur. Resp. J. 1999; 13: 301- 306.Dotsch J., Demirakca S., Terbrack H. G. et al. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur. Resp. J. 1996; 9: 2537- 2540.Dotsch J., Demirakca S., Terbrack H. G. et al. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur. Resp. J. 1996; 9: 2537- 2540.Baraldi E., Azzolin N.M., Biban P., Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am. J. Respir. Crit Care Med. 1997; 155: 1680-1583.Baraldi E., Azzolin N.M., Biban P., Zacchello F. Effect of antibiotic therapy on nasal nitric oxide concentration in children with acute sinusitis. Am. J. Respir. Crit Care Med. 1997; 155: 1680-1583.Lindberg S., Cervin A., Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol. 1997; 117: 113-117.Lindberg S., Cervin A., Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Otolaryngol. 1997; 117: 113-117.Chng S.Y., Van Bever H.P., Lian D. et al. Relationship between exhaled nitric oxide and atopy in Asian young adults. Respirology; 2005; 10(1):40-5.Chng S.Y., Van Bever H.P., Lian D. et al. Relationship between exhaled nitric oxide and atopy in Asian young adults. Respirology; 2005; 10(1):40-5.Henriksen A.H., Lingaas-Holmen T., Sue-Chu M., Bjermer L. Combined use of exhaled nitric oxide and airway hyperesponsiveness in characterizing asthma in a large population survey. Eur. Resp. J. 2000; 15: 849-855.Henriksen A.H., Lingaas-Holmen T., Sue-Chu M., Bjermer L. Combined use of exhaled nitric oxide and airway hyperesponsiveness in characterizing asthma in a large population survey. Eur. Resp. J. 2000; 15: 849-855.Silverstri M., Spallarossa D., Frangova Yourukova V. et al. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mildintermittent asthma. Eur. Resp. J. 1999; 13: 321-326.Silverstri M., Spallarossa D., Frangova Yourukova V. et al. Orally exhaled nitric oxide levels are related to the degree of blood eosinophilia in atopic children with mildintermittent asthma. Eur. Resp. J. 1999; 13: 321-326.Mattes J., Storm van's Gravesande K., Reining U., et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependant childhood asthma. Eur. Resp. J. 1999; 13: 1391-1395.Mattes J., Storm van's Gravesande K., Reining U., et al. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependant childhood asthma. Eur. Resp. J. 1999; 13: 1391-1395.Simpson A., Custovic A., Pipis S. et al. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am. J. Respir. Crit. Care Med. 1999; 160: 45-49.Simpson A., Custovic A., Pipis S. et al. Exhaled nitric oxide, sensitization, and exposure to allergens in patients with asthma who are not taking inhaled steroids. Am. J. Respir. Crit. Care Med. 1999; 160: 45-49.Baraldi E., Carra S., Dario C. et al. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am. J. Respir. Crit. Care Med. 1999; 159: 262-266.Baraldi E., Carra S., Dario C. et al. Effect of natural grass pollen exposure on exhaled nitric oxide in asthmatic children. Am. J. Respir. Crit. Care Med. 1999; 159: 262-266.
The authors declare that there are no conflicts of interest present.